Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Photodynamic Treatment for Premalignant Oral Mucosal Lesions
2010-018399-25Phase 3Completed
- Sponsor
- Medical University of Vienna
- Start
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of 5-aminolevulinic acid in leukoplakia and oral lichen planus (OLP) (2 arms), sponsored by Medical University of Vienna. Primary endpoint: Reduction in lesion size. Started Feb 2011; status: completed.
02
Drugs
5-aminolevulinic acid
03
Conditions
leukoplakiaoral lichen planus (OLP)
Beyond the preview
Go deeper on 2010-018399-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018399-25.